Aveta Biomics, Inc.
Aveta Biomics, Inc.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-05 | NCT06011109 | |
| APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Stomatognathic Diseases, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, mouth disorder, neoplasm, oral cavity carcinoma, oropharynx squamous cell carcinoma, squamous cell carcinoma | Not yet recruiting | Phase 3 | 2026-07-01 | NCT07667296 | |
| Safety and Efficacy of APG-157 in Head and Neck Cancer | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, mouth disorder, neoplasm, oral cavity squamous cell carcinoma, otorhinolaryngologic disease, squamous cell carcinoma | Active, not recruiting | Phase 2 | 2026-01-16 | NCT05312710 | |
| A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia | Oral Carcinoma in Situ; Oral Cavity Dysplasia; Oropharyngeal Dysplasia | Recruiting | Phase 2 | 2026-01-14 | NCT05865028 |